This image provided by Novo Nordisk on Friday, June 4, 2021 shows a package of injection pens for the company's semaglutide medication, named Wegovy. People taking the popular diabetes and obesity drugs Ozempic and Wegovy had a lower risk of suicidal thoughts than those taking other medications to treat the same conditions, according to research, funded by the U.S. National Institutes of Health, published Friday, Jan. 5, 2023. It comes as European and U.S. regulators look into anecdotal reports that people taking the drug, semaglutide, had thoughts of self-harm. (Novo Nordisk via AP, file)